ArticlePloS one2017
Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.
Nadeeka H De Silva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it